Citation: koertke et al.Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants.Eur heart j.2015 jun 1;36(21):1297-305.Doi: 10.1093/eurheartj/ehu330.Epub 2014 sep 9.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding low-dose international normalized ratio self-control in patients with mechanical heart valve implants.All data were collected from multiple centers from january 2006 to april 2012.The study population included 1,571 patients who were predominantly male with an approximate mean age of 58 years.Multiple manufacturer¿s devices were implanted in the study population; eight patients were implanted with medtronic mechanical prosthetic heart valves (model and/or unique device identifier numbers were not provided).Among all patients, 29 deaths occurred due to: myocardial infarction, sepsis, tumor, sudden cardiac death, aortic aneurysm, surgery-related bleeding, cardiac failure, kidney failure, sepsis, and multiple organ failure.Based on the available information medtronic product was not directly associated with the death(s).Among all patients, adverse events included: major bleeding complications, and thrombotic events resulting in stroke, transient ischemic attack (tia), or ischemia.Another outcome of stenosis was stated as being unrelated to a valve.Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
|